Toxicity and compliance with a chemoradiotherapy schedule for advanced nasopharyngeal carcinoma: A single institution experience using the Intergroup 0099 study regimen

Author： Chajón Enrique   García-Berrocal Maria Isabel   Fuente Cristina De La   Regueiro Carlos   Romero Jesús   Valcárcel Francisco   Magallón Rosa   Hernanz Raúl   Torre Alejandro De La  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.44, Iss.1, 2005-02, pp. : 85-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma

By      

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 1123-1130

Spandidos Publications

Access to resources Recommend Favorite

The long‐term outcomes of alternating chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multiinstitutional phase II study

By  

Cancer Medicine, Vol. 4, Iss. 8, 2015-08 ,pp. : 1186-1195

John Wiley & Sons Inc

Access to resources Recommend Favorite

Timing of Chemoradiotherapy and Patient Selection for Locally Advanced Nasopharyngeal Carcinoma

By Sanguineti G.   Bossi P.   Pou A.   Licitra L.  

Clinical Oncology, Vol. 15, Iss. 8, 2003-12 ,pp. : 451-460

Elsevier

Access to resources Recommend Favorite

Long-term results and prognostic factors in patients with stage III–IVA squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy from a single institution study

By Kudaka Wataru   Nagai Yutaka   Toita Takafumi   Inamine Morihiko   Asato Kozue   Nakamoto Tomoko   Wakayama Akihiko   Ooyama Takuma   Tokura Akemi   Murayama Sadayuki   Aoki Yoichi  

International Journal of Clinical Oncology, Vol. 18, Iss. 5, 2013-10 ,pp. : 916-921

Springer Publishing Company

Access to resources Recommend Favorite

Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study

By Paglino Chiara   Imarisio Ilaria   Ganini Carlo   Morbini Patrizia   Vercelli Alessandro   Bregant Cristina   Porta Camillo  

Future Oncology, Vol. 8, Iss. 12, 2012-12 ,pp. : 1605-1612

Future Medicine

Access to resources Recommend Favorite